TURKEY PHARMA MARKET & REGULATORY REPORT
Turkey given the significant regulatory issues, ranging from weak patent enforcement, preferential reimbursement policies, the state's aggressive pricing policies and regulatory approval delays. Pharmaceutical trade Turkey's Vision 2025, which aims to boost local pharmaceutical production, will reduce the trade
Express Pharma - #DoP seeks #MHA intervention for... | Facebook
#DoP seeks #MHA intervention for uninterrupted #pharma #ancillary supplies https://j.mp/2X47vLA | #pharmanews. Jump to. Sections of this page. Accessibility Help.
Pharma industry seeks DoP intervention to address issue
Pharma industry seeks DoP intervention to address issue of increase in prices of APIs from 11% to 51% over one month Increase in costs of APIs, excipients, packing material and...
Pharma industry calls for revival of ancillary units to
According to industry estimates, the size of the ancillary industry is approximately $9 billion and is a key contributor to the growth of the pharma industry. Further, MSMEs have a significant...
DoP asks pharma associations to provide ancillary units list
DoP asks pharma associations to provide ancillary units list, uninterrupted pharma supplies Associations have asked member companies to submit the requested data on a priority basis and will be presenting to the department in the next two to three days
